Greiner AG – Trademark Portfolio
Entity Type: 25
Greiner AG holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 4 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 9 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include GREINER.
Greinerstraße 70
A-4550 Kremsmünster
Showing of trademarks Trademarks
Trademark Classifications
Greiner AG's trademark portfolio spans 9 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Machines and machine tools; motors and engines; machine coupling and transmission components
Common metals and their alloys; metal building materials; transportable buildings of metal
Frequently Asked Questions
How many trademarks does Greiner AG have?
Greiner AG has 4 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 abandoned.
What trademark classes does Greiner AG file in?
Greiner AG files trademarks across 9 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals), Class 16 (Paper Goods), Class 9 (Computers & Electronics), Class 12 (Vehicles). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are Greiner AG's most well-known trademarks?
Greiner AG's registered trademark portfolio includes well-known marks such as GREINER. These are among 2 currently registered trademarks in the portfolio.
What is Greiner AG's trademark registration success rate?
Greiner AG has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.